114 related articles for article (PubMed ID: 15737031)
1. Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Ramos RY; Haupt HM; Kanetsky PA; Donthineni-Rao R; Arenas-Elliott C; Lackman RD; Martin AM
Arch Pathol Lab Med; 2005 Mar; 129(3):360-5. PubMed ID: 15737031
[TBL] [Abstract][Full Text] [Related]
2. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
3. The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter.
Mansky KC; Sulzbacher S; Purdom G; Nelsen L; Hume DA; Rehli M; Ostrowski MC
J Leukoc Biol; 2002 Feb; 71(2):304-10. PubMed ID: 11818452
[TBL] [Abstract][Full Text] [Related]
4. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation.
Partington GA; Fuller K; Chambers TJ; Pondel M
Bone; 2004 Feb; 34(2):237-45. PubMed ID: 14962802
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of microphthalmia-associated transcription factor expression in giant cell lesions.
Seethala RR; Goldblum JR; Hicks DG; Lehman M; Khurana JS; Pasha TL; Zhang PJ
Mod Pathol; 2004 Dec; 17(12):1491-6. PubMed ID: 15205688
[TBL] [Abstract][Full Text] [Related]
6. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
Connor JR; Dodds RA; James IE; Gowen M
J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
[TBL] [Abstract][Full Text] [Related]
7. Similarities between giant cell tumor of bone, giant cell tumor of tendon sheath, and pigmented villonodular synovitis concerning ultrastructural cytochemical features of multinucleated giant cells and mononuclear stromal cells.
Anazawa U; Hanaoka H; Shiraishi T; Morioka H; Morii T; Toyama Y
Ultrastruct Pathol; 2006; 30(3):151-8. PubMed ID: 16825116
[TBL] [Abstract][Full Text] [Related]
8. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB.
Ripoll VM; Meadows NA; Raggatt LJ; Chang MK; Pettit AR; Cassady AI; Hume DA
Gene; 2008 Apr; 413(1-2):32-41. PubMed ID: 18313864
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
10. Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor.
Matsumoto M; Hisatake K; Nogi Y; Tsujimoto M
J Biol Chem; 2001 Aug; 276(35):33086-92. PubMed ID: 11425859
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
12. miRNA-340 inhibits osteoclast differentiation via repression of MITF.
Zhao H; Zhang J; Shao H; Liu J; Jin M; Chen J; Huang Y
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607030
[TBL] [Abstract][Full Text] [Related]
13. Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase.
Janckila AJ; Walton SP; Yam LT
Biotech Histochem; 1998 Nov; 73(6):316-24. PubMed ID: 9888357
[TBL] [Abstract][Full Text] [Related]
14. Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.
Choi J; Choi SY; Lee SY; Lee JY; Kim HS; Lee SY; Lee NK
Cell Signal; 2013 May; 25(5):1222-7. PubMed ID: 23434822
[TBL] [Abstract][Full Text] [Related]
15. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.
Hu R; Sharma SM; Bronisz A; Srinivasan R; Sankar U; Ostrowski MC
Mol Cell Biol; 2007 Jun; 27(11):4018-27. PubMed ID: 17403896
[TBL] [Abstract][Full Text] [Related]
16. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.
Luchin A; Suchting S; Merson T; Rosol TJ; Hume DA; Cassady AI; Ostrowski MC
J Biol Chem; 2001 Sep; 276(39):36703-10. PubMed ID: 11481336
[TBL] [Abstract][Full Text] [Related]
17. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
18. Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo.
Iitsuka N; Hie M; Nakanishi A; Tsukamoto I
Int J Mol Med; 2012 Jul; 30(1):165-72. PubMed ID: 22576626
[TBL] [Abstract][Full Text] [Related]
19. The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia.
Akkaya H; Dogan O; Agan M; Dincol G
APMIS; 2005 Mar; 113(3):162-6. PubMed ID: 15799758
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]